1. Benetos, A., Gavras, H., Stewart, J. M. Vavrek, R. J., Hatinoglou, S., Gavras, I., 1986, Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist, Hypertension, 8: 971.
2. Blaine, E. H., Nelson, B. J., Seymour, A. A., Schorn, T. W., Sweet, C. S., Slater, E. E., Nussberger, J., Boger, J., 1985, Comparison of renin and converting enzyme inhibition in sodium-deficient dogs, Hypertension, 7: I66.
3. Burton, J., 1984, The design of substrate analog inhibitors of highly specific proteases, in: “Conformâtionally Directed Drug Design,” J. A. Vida, M. Gordon, American Chemical Society, Washington.
4. Haddy, F. J., Emerson, T. E., Jr., Scott, J. B., Daugherty, R. M., Jr., 1970, The effects of kinins on the cardiovascular system, in: “Handbook of experimental pharmacology, X XV Suppl.” E. G. Erdos, Springer Verlag, New York.
5. Fritz, H., Fink, E., Truscheit, E., 1979, Kallikrein inhibitors, Fed. Proc., 38: 2753.